Janus Henderson Group
DNTH icon

Janus Henderson Group’s Dianthus Therapeutics DNTH Stock Holding History

Janus Henderson Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Buy
16,500
+8,100
+96% +$469K ﹤0.01% 1541
2025
Q4 		$346K Buy
+8,400
New +$326K ﹤0.01% 2152
2025
Q2 		– Sell
-683,616
Closed -$13.7M – 2429
2025
Q1 		$13.7M Sell
683,616
-402,032
-37% -$8.86M 0.01% 641
2024
Q4 		$23.6M Buy
1,085,648
+136,314
+14% +$3.51M 0.01% 541
2024
Q3 		$25.9M Buy
949,334
+273,670
+41% +$7.62M 0.01% 522
2024
Q2 		$17.6M Buy
675,664
+300,620
+80% +$7.23M 0.01% 591
2024
Q1 		$11.3M Buy
+375,044
New +$8.15M 0.01% 671
2022
Q4 		– Sell
-206,806
Closed -$4.75M – 2466
2022
Q3 		$4.75M Buy
206,806
+19,070
+10% +$522K ﹤0.01% 836
2022
Q2 		$3.57M Buy
187,736
+68,066
+57% +$1.68M ﹤0.01% 916
2022
Q1 		$5.53M Buy
119,670
+110,173
+1,160% +$6.02M ﹤0.01% 994
2021
Q4 		$672K Sell
9,497
-27,778
-75% -$2.79M ﹤0.01% 1711
2021
Q3 		$4.34M Buy
37,275
+30,109
+420% +$3.51M ﹤0.01% 1088
2021
Q2 		$1.12M Sell
7,166
-6,741
-48% -$1.24M ﹤0.01% 1311
2021
Q1 		$2.63M Buy
+13,907
New +$2.34M ﹤0.01% 1137

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Janus Henderson Group's DNTH Position: Q1 2026 in Review

Janus Henderson Group increased its Dianthus Therapeutics (DNTH) stake by 96% in Q1 2026, buying an estimated $469K and bringing the position to 16,500 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Janus Henderson Group first reported a position in DNTH in Q1 2021 and has held it in 14 quarters since. The position peaked at $25.9M in Q3 2024. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Janus Henderson Group held 16,500 shares of Dianthus Therapeutics worth $1.38M as of Q1 2026.
  • Janus Henderson Group bought 8,100 Dianthus Therapeutics shares in Q1 2026, an estimated $469K.
  • Dianthus Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1541 holding.
  • Janus Henderson Group first reported a position in Dianthus Therapeutics in Q1 2021 and has held it in 14 quarters since.
  • Janus Henderson Group's Dianthus Therapeutics position peaked at $25.9M in Q3 2024.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.